Mandate

Vinge advises Alder in connection with its new majority ownership in Powerbox International

August 30, 2013

Powerbox International is one of Europe's leading manufacturers and distributors of power converters and associated products. It now has a new majority owner in Alder, a private equity fund based in Stockholm, Sweden. Founded in 1974, Powerbox International develops, manufactures and markets power supply solutions in AC/DC or DC/DC, ranging from a few watts to tens of kilowatts for demanding applications and customers. The company has an international reach with subsidiaries in 16 countries in Europe, the US and the Asia/Pacific region.

Alder is the new majority owner, with Industrifonden as well as current and previous employees of the company remaining as minority shareholders. Alder is an active investor and will, together with management, develop the company so that it reaches its full potential. As part of the transaction, new capital is invested in the company to help strengthen the organisation to enable future growth.

Vinges team consisted primarily of partners Johan Larsson and Jonas Bergström and associates Gustav Jönsson, Linn Adelwald and Philip Watson.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026